BIO-key International, Inc.

BIO-key International, Inc.

OOTC:BKYI
- -
USD
- -
- -
-6.53EPS
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
747.73
1,172.33
1,376.92
767.15
1,367.54
501.74
229.58
108.63
118.15
155.99
138.41
33.64
8.93
7.25
Basic EPS, GAAP
-972.2
-551.24
-521.11
-1,286.98
-1,094.49
-876.68
-1,477.04
-370.44
-117.03
-264.64
-152.1
-20.88
-10.77
-6.53
Free Cash Flow per Basic Share
-1,010.51
-732.49
-4,072.26
-1,146.39
-548.09
-203.93
-187.51
-189.55
-207.42
-138.41
-67.71
-14.15
-7.02
-4.5
Dividend per Share
- -
- -
- -
137.95
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
313.62
198.76
4,745.07
3,652.3
2,575.04
1,078.32
-226.95
468.4
357.9
103.83
10.3
10.15
4.71
3.99
Tangible Book Value per Share
261.41
156.51
2,829.32
1,115.65
1,055.68
358.51
-249.61
403.09
298.09
69.31
-3.33
7.2
3.94
3.33
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
Sales/Revenue/Turnover
2
4
5
3
6
4
2
3
5
7
8
7
6
7
Operating Margin (%)
-126.97
-50.9
-32.24
-141.2
-67.83
-169.83
-289.4
-171.4
-97.8
-120.93
-113.82
-57.88
-72.89
-49.12
Depreciation Expense
- -
- -
- -
- -
2
2
1
- -
1
1
- -
- -
- -
- -
Net Income, GAAP
-3
-2
-2
-4
-4
-7
-15
-10
-5
-12
-9
-4
-7
-6
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-130.02
-47.02
-35.3
-140.79
-67.83
-169.83
-643.37
-341.02
-99.05
-169.65
-109.89
-62.06
-120.55
-90.1
Working Capital
1
- -
11
3
5
3
-3
17
12
4
-1
-3
1
1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
1
1
18
15
14
10
-2
20
16
5
1
4
5
4
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-208.13
-21.06
-29.71
-34.54
-58.36
- -
- -
-28.18
-113.88
-267.77
-177.88
-161.24
-107.91

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
- -
- -
- -

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
5
4
4
Cash, Cash Equivalents & STI
3
2
1
Accounts Receivable, Net
1
2
2
Inventories
- -
- -
- -
Total Current Liabilities
3
3
3
Payables & Accruals
1
2
2
ST Debt
1
1
1
Deferred Revenue
1
1
1

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-104.06%
24.17%
35.39%
Free Cash Flow
7.91%
9.74%
60.21%
Net Income, GAAP
34.29%
15.18%
66.44%
Sales/Revenue/Turnover
11.68%
20.61%
-14.32%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
1
2
1
7
2025
2
2
2
1
6
2026
2
2
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-3.16
-10.02
-3.91
-4.57
-20.88
2025
-1.57
-2.01
-1.46
-4.62
-10.77
2026
-0.19
-0.56
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Michael W. DePasquale
Sector
Technology services
Industry
Information technology services
Address
United States
Business
BIO-key International, Inc. provides identity and access management (IAM), identity-bound biometric authentication, and workforce access security solutions to enterprise, government, healthcare, financial, and educational institutions worldwide. Founded in 1993 and headquartered in Wall Township, New Jersey, the company develops software and hardware solutions designed to secure user access, prevent credential-based cyberattacks, and ensure regulatory compliance. The company operates primarily through its identity security and authentication segment, offering core software platforms including PortalGuard and PortalGuard IDaaS (Identity-as-a-Service), a centralized enterprise IAM platform providing multi-factor authentication (MFA), single sign-on (SSO), contextual access control, and self-service password reset; WEB-key, a scalable biometric identification and authentication engine for enterprise and cloud environments; MobileAuth, a mobile biometric authentication application featuring PalmPositive contactless palm scanning and facial recognition; Swivel Secure authentication solutions for adaptive risk-based access; and ID-Director, an identity management tool integrated with Microsoft Windows Active Directory. In addition to its software suite, the company designs and distributes biometric hardware devices, including compact USB fingerprint readers such as SidePass, EcoID, SideSwipe, and PIV-Pro, as well as providing customer support, integration, and professional identity consulting services. The company distributes its solutions globally across North America, Europe, the Middle East, and Africa through direct sales forces and an established network of channel partners, systems integrators, and distributors, supported by operating subsidiaries including Swivel Secure Europe S.L. and PistolStar, Inc. In recent developments, BIO-key International transitioned its common stock listing from the Nasdaq Capital Market to the OTC Markets (OTC: BKYI) while undertaking corporate streamlining initiatives to optimize operating expenses and accelerate recurring software-as-a-service (SaaS) revenue. The company has recently expanded its biometric passwordless capabilities with advanced updates to its MobileAuth PalmPositive technology, secured strategic channel partnerships and multi-year identity deployment contracts across higher education and defense sectors, and broadened its FIDO2-certified authentication offerings to address stringent cyber insurance and zero-trust identity architecture requirements.